Paper5319962
Progress and perspectives in the chemotherapy of acute leukemia.
Frei E and 1 other. Adv Chemother, 1965. Cited by 90 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Progress and perspectives in the chemotherapy of acute leukemia. Papers, record 5319962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5319962
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Leukemia | Major topic |
| Animals | |
| Child | |
| Child, Preschool | |
| Humans | |
| Prednisone |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,054,999 | Rethinking the role of synergy calculations in the next century of drug combination discovery. | Med | 2026 | https://conductscience.org/library/papers/42054999 | PubMed |
| 41,105,675 | Mathematical Oncology: How Modeling Is Transforming Clinical Decision-Making. | Cancer Res | 2025 | https://conductscience.org/library/papers/41105675 | PubMed |
| 39,502,318 | Clinical characteristics and treatment management of combined large cell neuroendocrine carcinoma, a subtype of large cell neuroendocrine carcinoma. | Front Oncol | 2024 | https://conductscience.org/library/papers/39502318 | PubMed |
| 35,842,290 | Drug independence and the curability of cancer by combination chemotherapy. | Trends Cancer | 2022 | https://conductscience.org/library/papers/35842290 | PubMed |
| 34,916,573 | Traits of a mussel transmissible cancer are reminiscent of a parasitic life style. | Sci Rep | 2021 | https://conductscience.org/library/papers/34916573 | PubMed |
| 30,781,344 | Targeting Tumor Microenvironment for Cancer Therapy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30781344 | PubMed |
| 27,198,897 | Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin. | AAPS J | 2016 | https://conductscience.org/library/papers/27198897 | PubMed |
| 21,297,755 | Acute leukemias in children. | Can Fam Physician | 1979 | https://conductscience.org/library/papers/21297755 | PubMed |
| 21,105,503 | Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor. | Nature | 1966 | https://conductscience.org/library/papers/21105503 | PubMed |
| 17,189,229 | Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells. | Int J Hematol | 2006 | https://conductscience.org/library/papers/17189229 | PubMed |
| 6,584,855 | Leukocyte, leukaemia and drugs. | Pharm Weekbl Sci | 1984 | https://conductscience.org/library/papers/6584855 | PubMed |
| 5,686,110 | [On the problem of the chemotherapeutic prevention of recurrence in malignant lymphogranulomatosis]. | Klin Wochenschr | 1968 | https://conductscience.org/library/papers/5686110 | PubMed |
| 5,587,222 | Cellular kinetics, cell cycles and cell killing. | Biophysik | 1967 | https://conductscience.org/library/papers/5587222 | PubMed |
| 5,551,303 | Leukemia in children. | Calif Med | 1971 | https://conductscience.org/library/papers/5551303 | PubMed |
| 5,422,021 | Cell proliferation in human melanoma. | J Clin Invest | 1970 | https://conductscience.org/library/papers/5422021 | PubMed |
| 5,263,311 | [Survival time in chronic myelocytic leukemia dependent of individual disease-specific factor and therapy. Freiburg results 1947-1966]. | Klin Wochenschr | 1969 | https://conductscience.org/library/papers/5263311 | PubMed |
| 5,242,941 | [Chemotherapy of malignant blood diseases]. | Klin Wochenschr | 1967 | https://conductscience.org/library/papers/5242941 | PubMed |
| 5,227,717 | Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. | J Clin Invest | 1967 | https://conductscience.org/library/papers/5227717 | PubMed |
| 4,987,170 | Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. | J Clin Invest | 1970 | https://conductscience.org/library/papers/4987170 | PubMed |
| 4,851,085 | Combination chemotherapy. | Proc R Soc Med | 1974 | https://conductscience.org/library/papers/4851085 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5319962
GET https://conductscience.org/api/papers/v1/5319962/cited_by?page=2